Skip to main content
Erschienen in: Current Psychiatry Reports 10/2014

01.10.2014 | Attention-Deficit Disorder (A Rostain, Section Editor)

Using Stimulants to Treat ADHD-Related Emotional Lability

verfasst von: Jonathan Posner, Erica Kass, Leslie Hulvershorn

Erschienen in: Current Psychiatry Reports | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Emotional lability, or sudden strong shifts in emotion, commonly occurs in youth with attention-deficit/hyperactivity disorder. Although these symptoms are impairing and disruptive, relatively little research has addressed their treatment, likely due to the difficulty of reliable and valid assessment. Promising signals for symptom improvement have come from recent studies using stimulants in adults, children and adolescents. Similarly, neuroimaging studies have begun to identify neurobiological mechanisms underlying stimulants’ impact on emotion regulation capacities. Here, we review these recent clinical and neuroimaging findings, as well as neurocognitive models for emotional lability in ADHD, issues of relevance to prescribers and the important role of psychiatric comorbidity with treatment choices.
Literatur
1.
Zurück zum Zitat Barkley R. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 3rd ed. New York: Guilford Press; 2005. Barkley R. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 3rd ed. New York: Guilford Press; 2005.
2.•
Zurück zum Zitat Sobanski E et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010;51(8):915–23. This was one of the first papers to estimate the prevalence of emotional lability. It also related ratings of emotional lability to clinical features. Sobanski E et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010;51(8):915–23. This was one of the first papers to estimate the prevalence of emotional lability. It also related ratings of emotional lability to clinical features.
4.••
Zurück zum Zitat Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health. 2010;46(3):209–17. This paper highlighted the impact of emotional impairments in ADHD on children and adolescents’ quality of life. Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health. 2010;46(3):209–17. This paper highlighted the impact of emotional impairments in ADHD on children and adolescents’ quality of life.
5.
Zurück zum Zitat Rydell A-M, Berlin L, Bohlin G. Emotionality, emotion regulation, and adaptation among 5-to 8-year-old children. Emotion. 2003;3(1):30.PubMedCrossRef Rydell A-M, Berlin L, Bohlin G. Emotionality, emotion regulation, and adaptation among 5-to 8-year-old children. Emotion. 2003;3(1):30.PubMedCrossRef
6.
Zurück zum Zitat Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
7.
Zurück zum Zitat Leibenluft E et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatr. 2003;160(3):430.PubMedCrossRef Leibenluft E et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatr. 2003;160(3):430.PubMedCrossRef
8.
Zurück zum Zitat Copeland WE et al. Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatr. 2013;170(2):173–9.PubMedCrossRefPubMedCentral Copeland WE et al. Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatr. 2013;170(2):173–9.PubMedCrossRefPubMedCentral
9.
Zurück zum Zitat Stringaris A, Goodman R. Mood lability and psychopathology in youth. Psychol Med. 2009;39(8):1237.PubMedCrossRef Stringaris A, Goodman R. Mood lability and psychopathology in youth. Psychol Med. 2009;39(8):1237.PubMedCrossRef
10.
Zurück zum Zitat Becker A et al. Psychopathological screening of children with ADHD: strengths and difficulties questionnaire in a pan-European study. Eur Child Adolesc Psychiatry. 2006;15(1):i56–62.PubMedCrossRef Becker A et al. Psychopathological screening of children with ADHD: strengths and difficulties questionnaire in a pan-European study. Eur Child Adolesc Psychiatry. 2006;15(1):i56–62.PubMedCrossRef
11.
Zurück zum Zitat Strine TW, et al. Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder. Preventing chronic disease, 2006; 3(2). Strine TW, et al. Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder. Preventing chronic disease, 2006; 3(2).
12.
Zurück zum Zitat Barkley R, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. J Am Acad Child Adolesc Psychiatry. 2010;49(5):503–13.PubMed Barkley R, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. J Am Acad Child Adolesc Psychiatry. 2010;49(5):503–13.PubMed
13.
Zurück zum Zitat Spencer T et al. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study. Postgrad Med. 2011;123(5):50.PubMedCrossRefPubMedCentral Spencer T et al. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study. Postgrad Med. 2011;123(5):50.PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Barkley R. Deficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorder. J ADHD Relat Disord. 2010;1:5–37. Barkley R. Deficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorder. J ADHD Relat Disord. 2010;1:5–37.
15.
Zurück zum Zitat Hinshaw SP. Impulsivity, emotion regulation, and developmental psychopathology: specificity versus generality of linkages. Ann N Y Acad Sci. 2003;1008(1):149–59.PubMedCrossRef Hinshaw SP. Impulsivity, emotion regulation, and developmental psychopathology: specificity versus generality of linkages. Ann N Y Acad Sci. 2003;1008(1):149–59.PubMedCrossRef
16.
Zurück zum Zitat Sonuga-Barke EJ. Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition. Behav Brain Res. 2002;130(1–2):29–36.PubMedCrossRef Sonuga-Barke EJ. Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition. Behav Brain Res. 2002;130(1–2):29–36.PubMedCrossRef
17.
Zurück zum Zitat Barkley R. ADHD and the nature of self-control. New York: Guilford Press; 1997. Barkley R. ADHD and the nature of self-control. New York: Guilford Press; 1997.
18.
Zurück zum Zitat Barkley R. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65–94.PubMedCrossRef Barkley R. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65–94.PubMedCrossRef
19.
Zurück zum Zitat Barkley RA et al. Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol. 2001;29(6):541–56.PubMedCrossRef Barkley RA et al. Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol. 2001;29(6):541–56.PubMedCrossRef
20.
Zurück zum Zitat Nigg JT et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224–30.PubMedCrossRef Nigg JT et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224–30.PubMedCrossRef
22.
Zurück zum Zitat Brotman M et al. Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. Am J Psychiatr. 2010;167(1):61.PubMedCrossRefPubMedCentral Brotman M et al. Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. Am J Psychiatr. 2010;167(1):61.PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Hulvershorn L et al. Abnormal amygdala functional connectivity associated with emotional lability in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013. doi:10.1016/j.jaac.2013.11.012.PubMed Hulvershorn L et al. Abnormal amygdala functional connectivity associated with emotional lability in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013. doi:10.​1016/​j.​jaac.​2013.​11.​012.PubMed
24.
Zurück zum Zitat Sonuga-Barke EJ et al. Hyperactivity and delay aversion–I. The effect of delay on choice. J Child Psychol Psychiatry. 1992;33(2):387–98.PubMedCrossRef Sonuga-Barke EJ et al. Hyperactivity and delay aversion–I. The effect of delay on choice. J Child Psychol Psychiatry. 1992;33(2):387–98.PubMedCrossRef
25.
Zurück zum Zitat Sonuga-Barke E, Bitsakou P, Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(4):345–55.PubMed Sonuga-Barke E, Bitsakou P, Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(4):345–55.PubMed
26.••
Zurück zum Zitat Posner J et al. Abnormal amygdalar activation and connectivity in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(8):828–37. e3. This neuroimaging-phacmacolgical study suggests that stimulant treatment may normalize hyperactivation of the amygdala in youth with ADHD seen in response to the subliminal presenation of fearful faces. Posner J et al. Abnormal amygdalar activation and connectivity in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(8):828–37. e3. This neuroimaging-phacmacolgical study suggests that stimulant treatment may normalize hyperactivation of the amygdala in youth with ADHD seen in response to the subliminal presenation of fearful faces.
27.
Zurück zum Zitat Hulvershorn, L. The impact of methylphenidate on frontal activation in youth with disruptive mood dysregulation disorder, in 60th Annual Meeting of the American Academy of Child and Adolescent Psychiatry 2013; Orlando, FL. Hulvershorn, L. The impact of methylphenidate on frontal activation in youth with disruptive mood dysregulation disorder, in 60th Annual Meeting of the American Academy of Child and Adolescent Psychiatry 2013; Orlando, FL.
28.
Zurück zum Zitat Bradley C, Bowen M. Amphetamine (Benzedrine) therapy of children's behavior disorders. Am J Orthopsychiatry. 1941;11(1):92–103.CrossRef Bradley C, Bowen M. Amphetamine (Benzedrine) therapy of children's behavior disorders. Am J Orthopsychiatry. 1941;11(1):92–103.CrossRef
29.
Zurück zum Zitat Kaplan SL. Your child does not have bipolar disorder. Santa Barbara: ABC-CLIO, LLC; 2011. Kaplan SL. Your child does not have bipolar disorder. Santa Barbara: ABC-CLIO, LLC; 2011.
30.
Zurück zum Zitat Network UAA. Handbook for attention deficit hyperactivity disorder in adults. Heidelberg: Springer; 2013. Network UAA. Handbook for attention deficit hyperactivity disorder in adults. Heidelberg: Springer; 2013.
31.
Zurück zum Zitat Group MC. A 14-month randmonized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–86.CrossRef Group MC. A 14-month randmonized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–86.CrossRef
32.
Zurück zum Zitat Greenhill L et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93.PubMedCrossRef Greenhill L et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93.PubMedCrossRef
33.•
Zurück zum Zitat Reimherr FW et al. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93–101. Using a crossover, placebo-controlled design in a sample of 47 adults with ADHD, the authors report large improvements (effect size: 0.7) in emotional dysregulation following treatment with osmotic release oral system methylphenidate. Reimherr FW et al. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93–101. Using a crossover, placebo-controlled design in a sample of 47 adults with ADHD, the authors report large improvements (effect size: 0.7) in emotional dysregulation following treatment with osmotic release oral system methylphenidate.
34.
Zurück zum Zitat Rosler M et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2010;11(5):709–18.CrossRef Rosler M et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2010;11(5):709–18.CrossRef
35.
Zurück zum Zitat Marchant BK et al. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. J Atten Disord. 2011;15(4):295–304.PubMedCrossRef Marchant BK et al. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. J Atten Disord. 2011;15(4):295–304.PubMedCrossRef
36.••
Zurück zum Zitat Childress AC et al. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial. J Atten Disord. 2012. doi:10.1177/1087054712448252. This is the largest study of stimulant effects on emotional lablity in youth with ADHD and the findings suggest that lisdexamfetamine attenuates this symptom in highly emotional labile youth with ADHD.PubMed Childress AC et al. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial. J Atten Disord. 2012. doi:10.​1177/​1087054712448252​. This is the largest study of stimulant effects on emotional lablity in youth with ADHD and the findings suggest that lisdexamfetamine attenuates this symptom in highly emotional labile youth with ADHD.PubMed
37.
Zurück zum Zitat Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;62(9):954–62.PubMedCrossRef Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;62(9):954–62.PubMedCrossRef
38.
Zurück zum Zitat Marchant BK et al. Psychometric properties of the Wender-Reimherr adult attention deficit disorder scale. Psychol Assess. 2013;25(3):942–50.PubMedCrossRef Marchant BK et al. Psychometric properties of the Wender-Reimherr adult attention deficit disorder scale. Psychol Assess. 2013;25(3):942–50.PubMedCrossRef
39.
Zurück zum Zitat Schachter HM et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J. 2001;165(11):1475–88. Schachter HM et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J. 2001;165(11):1475–88.
40.
Zurück zum Zitat Kavale K. The efficacy of stimulant drug treatment for hyperactivity a meta-analysis. J Learn Disabil. 1982;15(5):280–9.PubMedCrossRef Kavale K. The efficacy of stimulant drug treatment for hyperactivity a meta-analysis. J Learn Disabil. 1982;15(5):280–9.PubMedCrossRef
41.
Zurück zum Zitat Biederman J et al. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450–63.PubMedCrossRef Biederman J et al. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450–63.PubMedCrossRef
42.
Zurück zum Zitat Pliszka SR et al. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(5):619–26.PubMedCrossRef Pliszka SR et al. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(5):619–26.PubMedCrossRef
43.
44.
Zurück zum Zitat Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatr. 1991;148(5):564–77.PubMed Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatr. 1991;148(5):564–77.PubMed
45.
Zurück zum Zitat Jensen PS et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–58.PubMedCrossRef Jensen PS et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–58.PubMedCrossRef
46.
Zurück zum Zitat Schatz DB, Rostain AL. ADHD with comorbid anxiety a review of the current literature. J Atten Disord. 2006;10(2):141–9.PubMedCrossRef Schatz DB, Rostain AL. ADHD with comorbid anxiety a review of the current literature. J Atten Disord. 2006;10(2):141–9.PubMedCrossRef
47.
Zurück zum Zitat Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28(6):882–7.PubMedCrossRef Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28(6):882–7.PubMedCrossRef
48.
Zurück zum Zitat Wolraich ML et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics. 1990;86(1):95–101.PubMed Wolraich ML et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics. 1990;86(1):95–101.PubMed
49.
Zurück zum Zitat Martinussen R et al. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(4):377–84.PubMedCrossRef Martinussen R et al. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(4):377–84.PubMedCrossRef
50.
Zurück zum Zitat Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1995;34(7):886–96.PubMedCrossRef Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1995;34(7):886–96.PubMedCrossRef
51.
Zurück zum Zitat Bedard A-C, Tannock R. Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord. 2008;11(5):546–57.PubMedCrossRef Bedard A-C, Tannock R. Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord. 2008;11(5):546–57.PubMedCrossRef
52.
Zurück zum Zitat Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999;38(4):402–9.PubMedCrossRef Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999;38(4):402–9.PubMedCrossRef
53.
Zurück zum Zitat Wolraich M et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.PubMedCrossRef Wolraich M et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.PubMedCrossRef
54.
Zurück zum Zitat Pliszka SR et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642–57.PubMedCrossRef Pliszka SR et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642–57.PubMedCrossRef
Metadaten
Titel
Using Stimulants to Treat ADHD-Related Emotional Lability
verfasst von
Jonathan Posner
Erica Kass
Leslie Hulvershorn
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Current Psychiatry Reports / Ausgabe 10/2014
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-014-0478-4

Weitere Artikel der Ausgabe 10/2014

Current Psychiatry Reports 10/2014 Zur Ausgabe

Geriatric Disorders (W McDonald, Section Editor)

Strategies for Successful Aging: A Research Update

Substance Use and Related Disorders (F Levin and E Dakwar, Section Editors)

Antagonist Models for Treating Persons With Substance use Disorders

Complex Medical-Psychiatric Issues (MB Riba, Section Editor)

Meaning-Centered Psychotherapy: A Form of Psychotherapy for Patients With Cancer

Attention-Deficit Disorder (A Rostain, Section Editor)

Managing the Risks of ADHD Treatments

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.